A Pilot Research Project on Outcome of Trauma Informed Stabilization Treatment (TIST) for Adults with Complex Trauma Symptoms After Childhood Trauma, At the Department of Trauma Treatment, Modum Bad, Norway

December 2, 2024 updated by: Modum Bad

Residential Group and Individual Trauma Informed Stabilization Therapy for Adult Survivors of Childhood Trauma

The purpose of the study is to examine the effects of residential group and individual Trauma Informed Stabilization Treatment (TIST) for complex symptoms in adult survivors of childhood trauma in a naturalistic observational study.

Study Overview

Status

Enrolling by invitation

Intervention / Treatment

Detailed Description

Adult survivors of childhood trauma have complex and diverse symptom profiles. The aim of the study is to examine the effects of theTrauma Informed Stabilization Treatment (TIST) model, developed by dr Janina Fisher, in adult survivors of childhood trauma.

32 patients will be recruited from referrals to an residential open door trauma clinic in Norway, Modum Bad. Patients will be admitted for in-patient pre-planned treatment over 11 weeks - consisting of individual therapy and group therapy using different modalities, all within the TIST approach and framework. Patients will be summoned for 6 day follow-up 8 months after treatment.

Study Type

Observational

Enrollment (Estimated)

32

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Buskerud
      • Vikersund, Buskerud, Norway, 3535
        • Modum Bad

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients will be recruited from referrals to the clinic after assessment of eligibilty criteria.

Description

Inclusion Criteria:

  • Adults ≥18 years
  • Complex symptom presentations connected to childhood trauma
  • All patients will have undergone outpatient therapy with insufficient effect
  • Most included patients will have a diagnosis of complex PTSD (diagnosed by M.I.N.I. and clinical evaluation)
  • Patients may have diagnosis of unspecified dissociative disorder, personality disorders, depression and other comorbidity.

Exclusion criteria:

  • Dissociative identitiy disorder
  • Ongoing psychosis
  • Ongoing drug addiction
  • Very disturbed group function
  • Ongoing life crisis
  • Mental disability
  • Acute suicidality
  • Ongoing severe self harm
  • Patients with complex dissociative disorders and patients eligible for exposure therapy will be referred to/prioritized for other treatment programmes.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Treatment
All group and individual therapy will be in line with the Trauma Informed Stabilization Treatment (TIST) model, developed by dr Janina Fisher. Patients will be admitted for in-patient pre-planned treatment over 11 weeks in an open door psychiatric hospital. Patients will be summoned for 6 day follow-up 8 months after discharge.
During 11 weeks admission the programme will include group sessions using different modalities (psychoeducation videos, live psychoeducation groups, expressive arts therapy, equine facilitated therapy, mindfulness and discussion groups) all using TIST methodology. Parallell individual therapy with therapist (psychologist or psychiatrist) and milieu therapist. All therapists will be trained minimum in TIST level 1 and recieve supervision from an expert TIST therapist.
Other Names:
  • TIST
  • Trauma Informed Stabilization Treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difficulties in emotion regulation scale (DERS)
Time Frame: Week 0 (Admission), week 11-12 (discharge) and 8 months follow up
Difficulties in emotion regulation scale, scale and subscales
Week 0 (Admission), week 11-12 (discharge) and 8 months follow up
Five facet mindfulness questionnaire (FFMQ)
Time Frame: Week 0 (Admission), week 11-12 (discharge) and 8 months follow up
Five facet mindfulness questionnaire, all subscales
Week 0 (Admission), week 11-12 (discharge) and 8 months follow up
Self-compassion scale long form (SCS-LF)
Time Frame: Week 0 (Admission), week 11-12 (discharge) and 8 months follow up
Self-compassion scale long form, scale and subscales
Week 0 (Admission), week 11-12 (discharge) and 8 months follow up
PTSD checklist for DSM-5 (PCL-5)
Time Frame: Week 0 (Admission), week 11-12 (discharge) and 8 months follow up
PTSD checklist for DSM-5, scale and subscales
Week 0 (Admission), week 11-12 (discharge) and 8 months follow up
International trauma questionnaire (ITQ)
Time Frame: Week 0 (Admission), week 11-12 (discharge) and 8 months follow up
International trauma questionnaire, scale and subscales
Week 0 (Admission), week 11-12 (discharge) and 8 months follow up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient health questionnaire 9 (PHQ-9)
Time Frame: Week 0 (Admission), week 11-12 (discharge) and 8 months follow up
Patient health questionnaire 9
Week 0 (Admission), week 11-12 (discharge) and 8 months follow up
Quality of life
Time Frame: Week 0 (Admission), week 11-12 (discharge) and 8 months follow up
Self report on scale of 0-10
Week 0 (Admission), week 11-12 (discharge) and 8 months follow up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 24, 2024

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

November 20, 2024

First Submitted That Met QC Criteria

December 2, 2024

First Posted (Estimated)

December 5, 2024

Study Record Updates

Last Update Posted (Estimated)

December 5, 2024

Last Update Submitted That Met QC Criteria

December 2, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • TIST pilot project

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on PTSD

Clinical Trials on Psychoterapy

Subscribe